Biopharmaceutical Research Company

172+ years of combined pharmaceutical, manufacturing, quality, and cannabis production expertise all under one roof. This is what makes BRC your partner in quality. Follow along on our journey and sign up for the newsletter to be the first to learn about our research and innovative products. https://lnkd.in/ecvetWqY (scroll to the bottom of the page for newsletter sign up) #cannabisindustry #cannabinoids #cannabisresearch

🌱 #Throwback to a Medical Cannabis Industry Milestone 🌱 As we continue to push the boundaries of cannabinoid science, we can't help but look back at one of the pivotal moments in our journey. In June 2021, we partnered with Segrasegra to receive the first export of Verified Segra Stock™ Cannabis plants to the USA. This historic shipment not only marked a significant milestone for us at BRC but also for the US cannabis industry as a whole. It represented one of the first imports of live Cannabis plants to a federally licensed US cultivator. Read more about it at https://lnkd.in/edCWQZdj With these standardized and validated starting materials, we've been able to ensure consistency and quality in our research efforts. It's a partnership that underscores our commitment to excellence and our dedication to understanding the therapeutic effects of cannabis in a scientific and federally regulated environment. Here's to many more years of innovation! 🌿🔬 #CannabisResearch #cannabisindustry #Innovation #Science #Partnership #Milestone #cannabinoidresearch

Are you following our journey on Twitter yet? Join us @BRCPharma https://lnkd.in/e4ZU92AT for the latest updates, industry insights, and behind-the-scenes looks at cannabinoid research. Let's continue the conversation on both platforms for a holistic view of the impact we're making in the field. Follow us on Twitter for real-time updates, and join our growing community of science enthusiasts and industry professionals. See you there! #cannabisindustry #cannabisresearch #CannabinoidScience #IndustryInsights #Twitter

🌍 World Science Day for Peace and Development 🌍 Today, we celebrate the profound impact of science on society and its potential to drive peace and development globally. At BRC, we're proud to contribute to this mission by advancing cannabinoid science for the betterment of humanity. Our research not only seeks to unlock the potential of cannabinoids but also to foster a deeper understanding and appreciation within our community. Let's continue to champion science as a tool for global progress! 🌱🔬 #WorldScienceDay #CannabinoidResearch #Innovation #cannabisindustry #medicalcannabis

We're thrilled to announce the newest addition to our team, Dr. Maria Grunwald, as Head of Business Development. With over 20 years in the biopharma industry, Maria brings a wealth of expertise to the table, including in strategic partnerships, fundraising, and company creation. Her prior companies include Dyax, Radius Health, AesRx, IsoPlexis, Dicerna, Genevant, and QurAlis. Relying on her track record of negotiating over 30 strategic agreements, Maria's role will be to initiate partnerships with pharmaceutical companies and negotiate the associated transactions. Maria performed her doctoral studies at Johns Hopkins University School of Medicine and holds an MBA from the MIT Sloan School of Management. Check our website for her full profile https://lnkd.in/eZQb2wXC Please join us in welcoming Dr. Maria Grunwald! #TeamBRC #cannabisbusiness #cannabisindustry #medicalcannabis #cannabinoids

🟣 November is National Epilepsy Awareness Month 🟣 This month, we stand in solidarity with the millions of individuals and families affected by epilepsy. At BRC we're committed to supporting research that can improve the quality of life for those living with neurological conditions. Epilepsy is more than seizures; it's about the challenges and triumphs experienced by those who live with it every day. Let's use this month to spread awareness, educate, and advocate for better treatments and a deeper understanding. Join us in shining a light on epilepsy. #EpilepsyAwarenessMonth #epilepcy #cannabinoidresearch #cannabisindustry #NEAM

🌿 Exciting Opportunities at CannMed Events 24! 🌿 Our very own Vise President of Research & Development Hunter Land, PhD is an advisor for the CannMed 24 Innovation and Investment Summit! It's an honor to be part of a platform that brings together the brightest minds in cannabis science, medicine, cultivation, and analytical testing. As the abstract submission deadline approaches, we encourage our peers to share their groundbreaking work. This is more than a chance to present—it's a way to drive the conversation forward and contribute to the collective progress of our industry. We're looking forward to networking with industry experts, establishing thought leadership, and engaging in the stimulating debate that CannMed is known for. Let's advance the field together! For those interested in submitting, details can be found here: https://lnkd.in/e36EvEm6 #CannMed24 #CannabisScience #Innovation #IndustryLeadership

🌿 Exploring Cannabis in Alzheimer's Treatment: A recent study delves into the intricate enzyme-ligand relationship between active cannabis components and the human acetylcholinesterase (HuAChE) enzyme, a key player in Alzheimer's disease (AD). Using advanced computational methods, researchers found that two lesser-known cannabis phytochemicals, cannabichromene and cannabigerol, exhibit significant affinity for HuAChE. While their affinity was less than that of the pharmaceutical drug donepezil, it's essential to note their distinct binding mechanisms that might be crucial for future drug design. Though these findings signify an early step, they lay the groundwork for more in-depth studies into minor cannabinoids' role in AD treatment. More research is needed, but the potential therapeutic paths illuminated by this study are indeed promising. 🔬 #AlzheimersResearch #CannabisMedicine #NeurologicalDiseases #cannabinoidresearch #cannabisindustry https://lnkd.in/eXMPSUzT

Recent research sheds light on the neuroprotective potential of Cannabidiol (CBD) against the memory loss effects of Topiramate, a drug often used in neurology. This intriguing study underscores the ameliorative power of CBD in combating topiramate-induced cognitive decline in rats. Key Findings: 🧠 The combination of CBD and topiramate holds significant therapeutic promise. 🧠 CBD significantly reversed the memory loss induced by varying doses of topiramate. 🧠 This protective effect of CBD is linked to the NMDA receptors in the hippocampus and prefrontal cortex. 🧠 Crucially, these benefits might be governed by the CREB/BDNF signaling pathway. As we continue to understand the multifaceted effects of CBD, its combination with other drugs in treating neurological conditions could pave the way for more holistic therapeutic strategies. Exciting times ahead for neurology! 🔗 https://lnkd.in/e-Rrt4H4 #Cannabinoids #NeurologyResearch #CBD #cannabinoidresearch

If you want to stay up-to-date with us, follow our Page.